These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 35544131

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Cercek A, Boerner T, Tan BR, Chou JF, Gönen M, Boucher TM, Hauser HF, Do RKG, Lowery MA, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Schultz N, Kingham TP, D'Angelica MI, DeMatteo RP, Drebin JA, Allen PJ, Balachandran VP, Lim KH, Sanchez-Vega F, Vachharajani N, Majella Doyle MB, Fields RC, Hawkins WG, Strasberg SM, Chapman WC, Diaz LA, Kemeny NE, Jarnagin WR.
    JAMA Oncol; 2020 Jan 01; 6(1):60-67. PubMed ID: 31670750
    [Abstract] [Full Text] [Related]

  • 5. Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.
    Shapera E, Ross S, Pattilachan T, Christodoulou M, Sucandy I.
    Ann Surg Oncol; 2024 Jul 01; 31(7):4449-4451. PubMed ID: 38632219
    [Abstract] [Full Text] [Related]

  • 6. Robotic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrahepatic Cholangiocarcinoma.
    Ten Haaft BHEA, Franssen S, van Dorst RWJJ, Rousian M, Pilz da Cunha G, de Wilde RF, Erdmann JI, Groot Koerkamp B, Hagendoorn J, Swijnenburg RJ.
    Ann Surg Oncol; 2024 Jun 01; 31(6):4022-4029. PubMed ID: 38498089
    [Abstract] [Full Text] [Related]

  • 7. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
    Soares KC, Jolissaint JS, McIntyre SM, Seier KP, Gönen M, Sigel C, Nasar N, Cercek A, Harding JJ, Kemeny NE, Connell LC, Koerkamp BG, Balachandran VP, D'Angelica MI, Drebin JA, Kingham TP, Wei AC, Jarnagin WR.
    Cancer Med; 2023 Jun 01; 12(11):12272-12284. PubMed ID: 37062071
    [Abstract] [Full Text] [Related]

  • 8. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
    Konstantinidis IT, Groot Koerkamp B, Do RK, Gönen M, Fong Y, Allen PJ, D'Angelica MI, Kingham TP, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR.
    Cancer; 2016 Mar 01; 122(5):758-65. PubMed ID: 26695839
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE, Homs MYV, Grünhagen DJ, Filipe WF, Bennink RJ, Besselink MGH, Borel Rinkes IHM, Bruijnen RCG, Cercek A, D'Angelica MI, van Delden OM, Donswijk ML, van Doorn L, Doornebosch PG, Emmering J, Erdmann JI, IJzerman NS, Grootscholten C, Hagendoorn J, Kemeny NE, Kingham TP, Klompenhouwer EG, Kok NFM, Koolen S, Kuhlmann KFD, Kuiper MC, Lam MGE, Mathijssen RHJ, Moelker A, Oomen-de Hoop E, Punt CJA, Te Riele WW, Roodhart JML, Swijnenburg RJ, Prevoo W, Tanis PJ, Vermaas M, Versleijen MWJ, Veuger FP, Weterman MJ, Verhoef C, Groot Koerkamp B.
    BMC Cancer; 2019 Apr 05; 19(1):327. PubMed ID: 30953467
    [Abstract] [Full Text] [Related]

  • 10. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
    Martin RC, Edwards MJ, McMasters KM.
    Am J Surg; 2004 Dec 05; 188(6):714-21. PubMed ID: 15619489
    [Abstract] [Full Text] [Related]

  • 11. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Buisman FE, Filipe WF, Kemeny NE, Narayan RR, Srouji RM, Balachandran VP, Boerner T, Drebin JA, Jarnagin WR, Kingham TP, Wei AC, Grünhagen DJ, Verhoef C, Koerkamp BG, D'Angelica MI.
    Ann Surg Oncol; 2021 Feb 05; 28(2):808-816. PubMed ID: 32648182
    [Abstract] [Full Text] [Related]

  • 12. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
    Sposito C, Ratti F, Cucchetti A, Ardito F, Ruzzenente A, Di Sandro S, Maspero M, Ercolani G, Di Benedetto F, Guglielmi A, Giuliante F, Aldrighetti L, Mazzaferro V.
    J Hepatol; 2023 Feb 05; 78(2):356-363. PubMed ID: 36328332
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
    Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR.
    Ann Surg; 2008 Jul 05; 248(1):84-96. PubMed ID: 18580211
    [Abstract] [Full Text] [Related]

  • 14. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
    Sebastian NT, Tan Y, Miller ED, Williams TM, Noonan AM, Hays JL, Abdel-Misih S, Diaz DA.
    JAMA Netw Open; 2019 Sep 04; 2(9):e1911154. PubMed ID: 31517963
    [Abstract] [Full Text] [Related]

  • 15. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    Chakedis J, Beal EW, Sun S, Galo J, Chafitz A, Davidson G, Reardon J, Dillhoff M, Pawlik TM, Abdel-Misih S, Bloomston M, Schmidt CR.
    J Surg Oncol; 2018 Dec 04; 118(7):1065-1073. PubMed ID: 30376157
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
    Buisman FE, Grünhagen DJ, Homs MYV, Grootscholten C, Filipe WF, Kemeny NE, Cercek A, D'Angelica MI, Donswijk ML, van Doorn L, Emmering J, Jarnagin WR, Kingham TP, Klompenhouwer EG, Kok NFM, Kuiper MC, Moelker A, Prevoo W, Versleijen MWJ, Verhoef C, Kuhlmann KFD, Groot Koerkamp B.
    Ann Surg Oncol; 2019 Dec 04; 26(13):4599-4607. PubMed ID: 31641947
    [Abstract] [Full Text] [Related]

  • 17. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    Muaddi H, D'Angelica M, Wiseman JT, Dillhoff M, Latchana N, Roke R, Ko YJ, Carpizo D, Spencer K, Fields RC, Williams G, Aucejo F, Acevedo-Moreno LA, Billingsley KG, Walker BS, Mayo SC, Karanicolas PJ.
    J Surg Oncol; 2021 Jan 04; 123(1):252-260. PubMed ID: 33095919
    [Abstract] [Full Text] [Related]

  • 18. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U, Kaths JM, Heise M, Pitton MB, Weinmann A, Hoppe-Lotichius M, Otto G.
    Eur J Surg Oncol; 2013 Jun 04; 39(6):593-600. PubMed ID: 23611755
    [Abstract] [Full Text] [Related]

  • 19. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution.
    Xiao J, Zhu J, Liu Z, Wan R, Li Y, Xiao W.
    J Cancer Res Ther; 2017 Jun 04; 13(5):756-760. PubMed ID: 29237899
    [Abstract] [Full Text] [Related]

  • 20. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.
    Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR.
    Ann Surg Oncol; 2014 Aug 04; 21(8):2675-83. PubMed ID: 24664624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.